HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 194 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,017,915 | -52.9% | 157,537 | -52.9% | 0.00% | -50.0% |
| Q2 2023 | $12,778,681 | 0.0% | 334,608 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $12,778,681 | -56.7% | 334,608 | -35.5% | 0.01% | -60.0% |
| Q4 2022 | $29,501,455 | -99.9% | 518,479 | -0.3% | 0.02% | +25.0% |
| Q3 2022 | $20,558,863,000 | +164.2% | 519,951 | +194.0% | 0.01% | +200.0% |
| Q2 2022 | $7,782,016,000 | +16.5% | 176,864 | +5.6% | 0.00% | +33.3% |
| Q1 2022 | $6,678,504,000 | +10.1% | 167,465 | +11.0% | 0.00% | +50.0% |
| Q4 2021 | $6,066,403,000 | +0.9% | 150,868 | +2.1% | 0.00% | 0.0% |
| Q3 2021 | $6,009,982,000 | -14.8% | 147,738 | -4.9% | 0.00% | -33.3% |
| Q2 2021 | $7,051,947,000 | +11.9% | 155,295 | +2.8% | 0.00% | 0.0% |
| Q1 2021 | $6,299,442,000 | -4.3% | 151,102 | -2.0% | 0.00% | 0.0% |
| Q4 2020 | $6,584,901,000 | +77.5% | 154,177 | +9.2% | 0.00% | +50.0% |
| Q3 2020 | $3,710,736,000 | -4.8% | 141,200 | -2.9% | 0.00% | 0.0% |
| Q2 2020 | $3,897,958,000 | -75.2% | 145,392 | -83.3% | 0.00% | -81.8% |
| Q1 2020 | $15,708,723,000 | -16.3% | 873,192 | -17.5% | 0.01% | 0.0% |
| Q4 2019 | $18,764,172,000 | +36.1% | 1,058,329 | +19.1% | 0.01% | +22.2% |
| Q3 2019 | $13,787,429,000 | +586.3% | 888,938 | +660.2% | 0.01% | +800.0% |
| Q2 2019 | $2,008,909,000 | +24.6% | 116,933 | +16.8% | 0.00% | 0.0% |
| Q1 2019 | $1,612,400,000 | +18.3% | 100,149 | +7.5% | 0.00% | 0.0% |
| Q4 2018 | $1,362,770,000 | -15.9% | 93,149 | +4.5% | 0.00% | 0.0% |
| Q3 2018 | $1,620,127,000 | +6.8% | 89,165 | -0.8% | 0.00% | 0.0% |
| Q2 2018 | $1,516,681,000 | -10.8% | 89,904 | +3.5% | 0.00% | 0.0% |
| Q1 2018 | $1,701,176,000 | -0.4% | 86,839 | +3.0% | 0.00% | 0.0% |
| Q4 2017 | $1,708,344,000 | +25.7% | 84,321 | +7.7% | 0.00% | 0.0% |
| Q3 2017 | $1,359,515,000 | +23.5% | 78,268 | -8.9% | 0.00% | 0.0% |
| Q2 2017 | $1,100,943,000 | +25.3% | 85,877 | +26.6% | 0.00% | 0.0% |
| Q1 2017 | $878,986,000 | +119816.2% | 67,823 | -8.6% | 0.00% | 0.0% |
| Q4 2016 | $733,000 | -38.8% | 74,238 | -25.1% | 0.00% | 0.0% |
| Q3 2016 | $1,198,000 | +43.0% | 99,172 | +2.2% | 0.00% | 0.0% |
| Q2 2016 | $838,000 | -25.8% | 97,027 | -18.7% | 0.00% | 0.0% |
| Q1 2016 | $1,129,000 | -48.4% | 119,279 | -5.5% | 0.00% | -50.0% |
| Q4 2015 | $2,186,000 | +47.1% | 126,193 | +14.0% | 0.00% | 0.0% |
| Q3 2015 | $1,486,000 | -28.8% | 110,686 | +19.7% | 0.00% | 0.0% |
| Q2 2015 | $2,087,000 | +261.1% | 92,461 | +128.3% | 0.00% | +100.0% |
| Q1 2015 | $578,000 | +55.8% | 40,496 | +5.5% | 0.00% | – |
| Q4 2014 | $371,000 | +17.0% | 38,396 | +10.3% | 0.00% | – |
| Q3 2014 | $317,000 | -5.7% | 34,796 | +2.4% | 0.00% | – |
| Q2 2014 | $336,000 | -22.2% | 33,996 | 0.0% | 0.00% | – |
| Q1 2014 | $432,000 | -15.3% | 33,996 | 0.0% | 0.00% | -100.0% |
| Q4 2013 | $510,000 | -16.0% | 33,996 | -38.2% | 0.00% | 0.0% |
| Q3 2013 | $607,000 | -78.8% | 54,996 | -84.8% | 0.00% | -75.0% |
| Q2 2013 | $2,867,000 | – | 361,188 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 1,129,551 | $47,091,000 | 6.38% |
| First Light Asset Management, LLC | 2,011,350 | $83,853,000 | 5.56% |
| TRAN CAPITAL MANAGEMENT, L.P. | 1,353,208 | $56,415,000 | 5.03% |
| SNYDER CAPITAL MANAGEMENT L P | 2,920,860 | $121,771,000 | 3.50% |
| DOHENY ASSET MANAGEMENT /CA | 120,028 | $5,004,000 | 3.39% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 104,945 | $4,375,000 | 2.39% |
| Redwood Investments, LLC | 542,764 | $22,628,000 | 1.99% |
| Kent Lake Capital LLC | 85,000 | $3,544,000 | 1.44% |
| Lisanti Capital Growth, LLC | 263,460 | $10,984,000 | 1.41% |
| Bellevue Group AG | 3,011,966 | $125,569,000 | 1.33% |